TickerFacts.

Hyperfine, Inc. (HYPR): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$29.13M
Year ended 2025-12-31
-$27.53M
Trailing 12 months to 2026-06-30
2020-12-31: -$23.09M2021-12-31: -$49.89M2022-12-31: -$72.92M2023-12-31: -$42.61M2024-12-31: -$39.15M2025-12-31: -$29.13M-$29.13M
2020-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$29.13Mn/m2026-03-18, From 2025-01-01
2024-12-31-$39.15Mn/m2026-03-18, From 2024-01-01
2023-12-31-$42.61Mn/m2025-03-17, From 2023-01-01
2022-12-31-$72.92Mn/m2024-03-22, From 2022-01-01
2021-12-31-$49.89Mn/m2023-03-22, From 2021-01-01
2020-12-31-$23.09Mn/a2022-03-25, From 2020-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Hyperfine, Inc. (HYPR)2025-12-31-$29.13Mn/m
CapsoVision, Inc (CV)2025-12-31-$22.95Mn/m
Escalon Medical Corp (ESMC)2025-06-30$376.8Kn/m
QT Imaging Holdings, Inc. (QTI)2025-12-31-$9.08Mn/m
Precision Optics Corporation, Inc. (POCI)2025-06-30-$3.77Mn/m
Nuwellis, Inc. (NUWE)2025-12-31-$10.90Mn/m
electroCore, Inc. (ECOR)2025-12-31-$8.25Mn/a
Stereotaxis, Inc. (STXS)2025-12-31-$13.78Mn/m
Neuraxis, Inc (NRXS)2025-12-31-$6.46Mn/m

Compare HYPR, CV, ESMC, QTI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗